1. Pb A, Skp IDI, Lawrenti H. Tatalaksana Leukemia Mieloid Kronik.

2017;44:1–6.

2. Chakrabarti P, Chakrabarty S, Aich R, Nath U, Chaudhuri U, Ray S, et al.

Incidence of BCR-ABL transcript variants in patients with chronic myeloid

leukemia: Their correlation with presenting features, risk scores and

response to treatment with imatinib mesylate. Indian J Med Paediatr Oncol

[Internet]. 2014;35(1):26. Available from:

http://www.ijmpo.org/text.asp?2014/35/1/26/133707

3. Iurlo A, Orsi E, Cattaneo D, Resi V, Bucelli C, Orofino N, et al. Effects of

first- and second-generation tyrosine kinase inhibitor therapy on glucose and

lipid metabolism in chronic myeloid leukemia patients: a real clinical

problem? Oncotarget [Internet]. 2015;6(32):33944–51. Available from:

http://www.oncotarget.com/fulltext/5580

4. Larsson SC, Wolk A. Overweight and obesity and incidence of leukemia: A

meta-analysis of cohort studies. Int J Cancer. 2008;122(6):1418–21.

5. Strom SS, Yamamura Y, Kantarijian HM, Cortes-Franco JE. Obesity, weight

gain, and risk of chronic myeloid leukemia. Cancer Epidemiol Biomarkers

Prev. 2009;18(5):1501–6.

6. Reksodiputro A H. Epidemiology Study and Mutation Profile of Patients

with Chronic Myeloid Leukemia (CML) in Indonesia. J Blood Disord

Transfus [Internet]. 2015;6(3):1–13. Available from:

https://www.omicsonline.org/open-access/epidemiology-study-and-
 mutation-profile-of-patients-with-chronic-myeloid-leukemia-cml-in-

indonesia-2155-9864-1000271.php?aid=53370

7. Usman M, Syed NN, Kakepoto GN, Adil SN, Khurshid M. Hematological

and nonhematological toxities of imatinib mesylate in patients with chronic

myeloid leukemia and gastrointestinal stromal tumor. 2007;39(4).

8. DeGennaro LJ. Chronic Myeloid Leukemia. Leuk Lymphoma Soc. 2014;1–

56.

9. Surana S, Bari S, Adhikari S. Tyrosine Kinase Receptor Inhibitors: A New

Target for Anticancer Drug Development. J PharmaSciTech [Internet].

2012;1(2):36–45. Available from:

http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:Tyrosine

+Kinase+Receptor+Inhibitors+:+A+New+Target+for+Anticancer+Drug+D

evelopment#0%5Cnhttp://scholar.google.com/scholar?hl=en&btnG=Search

&q=intitle:Tyrosine+Kinase+Receptor+Inhibitors:+A+New+

10. Kang ZJ, Liu YF, Xu LZ, Long ZJ, Huang D, Yang Y, et al. The philadelphia

chromosome in leukemogenesis. Chin J Cancer. 2016;35(1):1–15.

11. Burmeister T, Reinhardt R. A multiplex PCR for improved detection of

typical and atypical BCR-ABL fusion transcripts. Leuk Res.

2008;32(4):579–85.